Quick Answer
MEDICURE INC reported R&D Expense of $3.08 million for fiscal year 2024.
MEDICURE INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $3.08M | +28.1% |
| 2023 | $2.41M | -12.6% |
| 2022 | $2.75M | +53.3% |
| 2021 | $1.80M | -45.6% |
| 2020 | $3.30M | -24.1% |
| 2019 | $4.35M | -34.9% |
| 2018 | $6.68M | +29.8% |
| 2017 | $5.15M | +41.8% |
| 2016 | $3.63M | -25.4% |
| 2015 | $4.87M | — |
- MEDICURE INC showed an increase of +28.1% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2024 period, MEDICURE INC’s r&d expense has declined by 36.7% (from $4.87 million to $3.08 million).
- The most recent figure is from MEDICURE INC’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: